The Leadership Team at Capsida Biotherapeutics is responsible for guiding the company's strategic direction, overseeing operational efficiency, and driving innovation in biotherapeutics. Comprising executives with expertise in research, technology, manufacturing, finance, and business development, the team collaborates to advance the development of therapies targeting both monogenetic and sporadic disorders, ensuring alignment with Capsida's mission while fostering a culture of scientific excellence and operational integrity.
Bethany Mancilla
Chief Business Officer
Christopher Octeau
Principal Scientist
Julie Hakim
Chief Financial Officer
Lysa-Anne Volpe
Principal Scientist, Plasmid &...
Nicholas Flytzanis
Chief Research And Innovation ...
Nick Goeden
Chief Technology Officer
Peter Anastasiou
CEO
Rob Murphy
Chief Manufacturing And Qualit...
Swati Tole M.D.
Chief Medical Officer
Troy Sandberg
Principal Scientist
View all